Given the central role of STAT3 pathway in HNSCC, despite its complexity, our data provide supportive evidence of STAT3 inhibition as a preventive and therapeutic approach in hypopharyngeal cancer. This evidence concerns the gene STAT3 and head and neck squamous cell carcinoma.